News

Press ReleaseCell and Gene Therapy Catapult and UCL Researcher-in-Residence to develop a digital twin of CAR-T manufacturing
Filter:AllGeneralRegulatory NewsNewsletterExternalManufacturingPress ReleaseSkills and TrainingChallenge Theme – PATChallenge Theme – AAVChallenge Theme – iPSCsNon ClinicalCommercialisation of Research
Year:All2025202420232022 →
Cell and Gene Therapy Catapult appoints three new Non-Executive Directors to the BoardCell and Gene Therapy Catapult appoints three new Non-Executive Directors to the BoardCell Therapy Catapult is now the Cell and Gene Therapy CatapultCell Therapy Catapult is now the Cell and Gene Therapy CatapultReNeuron wins major UK grant to advance its exosome nanomedicine platformReNeuron wins major UK grant to advance its exosome nanomedicine platformSynpromics and Cell Therapy Catapult collaborate to develop novel large scale viral vector manufacturing platform based on stable producer cell linesSynpromics and Cell Therapy Catapult collaborate to develop novel large scale viral vector manufacturing platform based on stable producer cell linesCell Therapy Catapult, University of Birmingham and Cancer Research Technology launch new collaboration for CAR-T cell immuno-oncology therapy developmentCell Therapy Catapult, University of Birmingham and Cancer Research Technology launch new collaboration for CAR-T cell immuno-oncology therapy developmentHorizon 2020 awards €6.8m to TETRA consortium for pivotal replacement trachea trialHorizon 2020 awards €6.8m to TETRA consortium for pivotal replacement trachea trialCell Therapy Catapult details key milestones and achievements in 2015 Annual ReviewCell Therapy Catapult details key milestones and achievements in 2015 Annual ReviewCell Therapy Catapult signs Memorandum of Understanding with Kanagawa Prefecture, JapanCell Therapy Catapult signs Memorandum of Understanding with Kanagawa Prefecture, JapanBIA publishes briefing paper on ATMPs and regenerative medicineBIA publishes briefing paper on ATMPs and regenerative medicineEMA releases new guidance on methods to be used in the design and conduct of post-authorisation efficacy studiesEMA releases new guidance on methods to be used in the design and conduct of post-authorisation efficacy studiesConstruction initiated on Cell Therapy Catapult’s £55 million cell and gene therapy manufacturing centreConstruction initiated on Cell Therapy Catapult’s £55 million cell and gene therapy manufacturing centreUS Guidance for Industry updateUS Guidance for Industry update